MARKET UPDATES CONSUMER 🔸 $BSET: Q1 EPS $0.21 (est. $0.03), rev $82.2M (est. $79.62M). 🔸 $LCID: Q1 production 2,212 vehicles, 600+ in transit; delivered 3,109; files to sell $1B in notes; guides Q1 revs $232M-$236M (est. $256.3M). 🔸 $LYFT: Downgraded to Underperform at BofA, tgt cut to $10.50. 🔸 $NKE, $ADDYY: Shares drop on new 46% Vietnam tariff (impacting AEO, W). 🔸 $RH: Q4 revs $812.4M (est. $829.6M), EPS $1.58 (est. $1.91); guides FY25 rev growth 10%-13%; warns of tariff risks. 🔸 $ROST, $TJX: Upgraded to Buy at Citi; tariffs boost off-price retail inventory. ENERGY, INDUSTRIALS & MATERIALS 🔸 $BALL, $CCK: Potential impact from new 25% tariff on canned beer, aluminum. 🔸 $EMN: Upgraded to Outperform at Mizuho, tgt $105 (+18% upside). 🔸 $LSTR: Q1 EPS cut to $0.90-$0.95 (prior $1.05-$1.25) due to supply chain fraud. 🔸 $MSM: Q2 EPS $0.72 in line, revs $891.72M (est. $908.3M). 🔸 $PCAR: CFO Harrie Schippers to retire; Brice Poplawski promoted. FINANCIALS 🔸 $RGP: Q3 adj. EBITDA $1.7M (est. -$0.5M), revs $129.4M (est. $130M). HEALTHCARE 🔸 $RXST: Cuts FY25 rev view to $160M-$175M (prior $185M-$197M). 🔸 $SRNA: Files for $100M mixed shelf. 🔸 Drugmakers ($AZN, $SNY, $NVO): Spared from Trump tariffs, benefiting exporters. 🔸 Medical Devices ($DXCM, $GHHC, $BSX, $ABT): Under pressure due to new tariffs (34% China, 20% EU). TECH, MEDIA & TELECOM 🔸 $MSFT: Pausing data center projects, impacting VRT, CRWV, ETN, SMCI, DELL, VST, SMR, OKLO, NRG, CEG. 🔸 $GCT: Increases buyback by $16M. 🔸 $PDD: Investing $13B over three years to support merchants. 🔸 $PENG: Q2 EPS $0.52 (est. $0.38), sales $366M (+29% y/y, est. $345.1M).

#Downgrades - Dec 06, 2024 • $ACDC: JPMorgan Downgrades to Underweight from Neutral - PT $7 • $DE: Jefferies Downgrades to Hold from Buy • $FTRE: Baird Downgrades to Neutral from Outperform - PT $25 (from $28) • $FYBR: Benchmark Downgrades to Hold from Buy • $KMT: Jefferies Downgrades to Hold from Buy • $NAPA: Jefferies Downgrades to Hold from Buy - PT $11 • $OGS: Ladenburg Thalmann Downgrades to Neutral from Buy - PT $75.50 • $PCAR: Jefferies Downgrades to Hold from Buy • $PLD: BMO Capital Downgrades to Underperform from Market Perform - PT $104 (from $120) • $TD: Scotiabank Downgrades to Sector Perform from Sector Outperform

#Upgrades - Nov 13, 2024 • $BMY: Daiwa Securities Upgrades to Outperform from Neutral - PT $65 (from $50) • $BKU: Wells Fargo Upgrades to Overweight from Equal Weight - PT $48 (from $38) • $CCCS: Morgan Stanley Upgrades to Overweight from Equalweight - PT $15 (from $14) • $CMI: Evercore ISI Upgrades to Outperform from In Line - PT $408 (from $294) • $DSP: Canaccord Upgrades to Buy from Hold - PT $18 (from $13) • $EQR: Stifel Upgrades to Buy from Hold - PT $81.50 (from $77.75) • $ONON: BTIG Upgrades to Buy from Neutral - PT $64 • $ONON: Williams Trading Upgrades to Buy from Hold - PT $60 (from $40) • $PCAR: Evercore ISI Upgrades to Outperform from In Line - PT $129 (from $99) • $PECO: Wolfe Research Upgrades to Outperform from Peerperform • $PFE: CFRA Upgrades to Buy from Hold - PT $30 • $TKR: Evercore ISI Upgrades to Outperform from In Line - PT $91 (from $87) • $TSLA: Phillip Securities Upgrades to Reduce from Sell - PT $230 (from $135) • $TSN: CFRA Upgrades to Buy from Hold - PT $74